Recommended Treatment for Pelvic Inflammatory Disease (PID)
The recommended first-line treatment for PID is ceftriaxone 500mg IM as a single dose plus doxycycline 100mg orally twice daily for 14 days, with metronidazole 500mg orally twice daily for 14 days added to provide anaerobic coverage. 1
Treatment Regimens Based on Severity
Outpatient Management (Mild to Moderate PID)
Recommended regimen:
Alternative regimen:
- Cefoxitin 2g IM as a single dose 1
- PLUS Doxycycline 100mg orally twice daily for 14 days
- PLUS Metronidazole 500mg orally twice daily for 14 days
Inpatient Management (Severe PID)
Recommended parenteral regimen:
- Cefoxitin 2g IV every 6 hours OR Cefotetan 2g IV every 12 hours 1
- PLUS Doxycycline 100mg orally/IV every 12 hours
Alternative parenteral regimen:
- Clindamycin 900mg IV every 8 hours 1
- PLUS Gentamicin loading dose IV or IM (2mg/kg) followed by maintenance dose (1.5mg/kg) every 8 hours
Continue parenteral therapy for at least 24-48 hours after clinical improvement, then transition to oral therapy to complete 10-14 days total treatment 1
Oral continuation therapy after improvement:
- Doxycycline 100mg orally twice daily to complete 14 days total OR
- Clindamycin 450mg orally 4 times daily to complete 14 days total 1
Criteria for Hospitalization
Patients should be hospitalized for PID treatment if they have:
- Uncertain diagnosis requiring further evaluation
- Surgical emergencies (e.g., appendicitis) cannot be excluded
- Pelvic abscess
- Pregnancy
- Severe illness, nausea and vomiting, or high fever
- Inability to tolerate or follow outpatient regimen
- Failed outpatient therapy
- Inability to arrange follow-up within 72 hours 1
Management of Pelvic Abscesses
For patients with tubo-ovarian abscess:
- Parenteral antibiotic therapy as outlined above 1
- Consider surgical or image-guided drainage if:
- No clinical improvement within 72 hours of antibiotic therapy
- Abscess is large or well-defined 1
Partner Treatment and Follow-up
- Sex partners of patients with PID should be referred for evaluation and empirically treated with regimens effective against C. trachomatis and N. gonorrhoeae 1
- All patients should be reevaluated within 72 hours to ensure clinical improvement 1
- Full 14-day course of antibiotics is essential to prevent treatment failure 1
Important Considerations
- PID is polymicrobial, requiring coverage for N. gonorrhoeae, C. trachomatis, anaerobes, gram-negative rods, and streptococci 1, 3
- Ceftriaxone has no activity against Chlamydia trachomatis, so doxycycline must be included in the regimen 2
- Inadequate duration of therapy can lead to treatment failure and long-term sequelae including infertility, ectopic pregnancy, and chronic pelvic pain 1, 3
- HIV-infected patients should receive the same treatment regimens but with closer monitoring 1
Common Pitfalls to Avoid
- Failing to provide the full 14-day course of antibiotics, which can lead to treatment failure 1
- Not including coverage for both N. gonorrhoeae and C. trachomatis 2, 3
- Neglecting to treat sexual partners, which can lead to reinfection 1
- Overlooking the need for surgical intervention in cases of tubo-ovarian abscess not responding to antibiotics 1
- Inadequate follow-up within 72 hours to ensure clinical improvement 1